Pacira BioSciences, Inc. (NASDAQ:PCRX) CEO Sells $197,211.42 in Stock

Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) CEO David M. Stack sold 5,058 shares of the company’s stock in a transaction on Tuesday, June 6th. The stock was sold at an average price of $38.99, for a total transaction of $197,211.42. Following the transaction, the chief executive officer now owns 159,107 shares of the company’s […]

Related Keywords

Canada ,Pacira Biosciences ,Royal Bank ,Barclays ,Pacira Biosciences Inc ,Pacira Biosciences Company Profile ,Quadrant Capital Group ,Group Wealth Management ,Nasdaq ,Financial Freedom ,Needham Company ,Get Rating ,Ivy Capital Management ,Capital Group ,Wealth Management ,Dark Forest Capital Management ,Forest Capital Management ,Pacira Biosciences Daily ,Nasdaq Pcrx ,Pcrx ,Medical ,69512710 ,Insider Trading ,Nsider Trades ,Stocks ,